Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: Collection of Transplant Stem Cells for Plasma Cell Myeloma [Phase 2]
Phase 2 clinical trial update on collection of transplant stem cells for multiple myeloma, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma [Phase 1]
Phase 1 trial evaluating bendamustine in combination with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma has comp…
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms
Completed clinical trial evaluating whether the final Geriatric Assessment in Haematology (GAH) score can predict tolerance to treatment in …
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer [Phase 1]
A Phase 1 trial of fenretinide in patients with refractory or relapsed hematologic cancers has been completed, investigating safety across m…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma [Phase 2]
Phase II results are reported for a regimen of Velcade (bortezomib) with Decadron (dexamethasone) and Doxil (liposomal doxorubicin), followe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 non-inferiority trial comparing XM02 (Granix) and filgrastim (Neupogen) when used with plerixafor for autologous stem cell mobiliz…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Preservation of Ovarian Function After Hematopoietic Cell Transplant [Phase 2]
Phase 2 trial investigating preservation of ovarian function after hematopoietic cell transplantation in patients with hematologic cancers; …
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen [Phase 1, Phase 2]
A Phase 1/2 trial evaluating allogeneic hematopoietic cell transplantation using a busulfan-based conditioning regimen across multiple hemat…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Post Transplant Donor Lymphocyte Infusion [Phase 2]
Phase 2 clinical trial update for post-transplant donor lymphocyte infusion; the study is terminated with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients [Phase 2]
Phase 2 trial update evaluating hemostatic effects of VELCADE treatment in patients with multiple myeloma; study terminated with posted resu…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation [Phase 1, Phase 2]
A completed Phase 1/2 sequential trial of reduced-intensity conditioning allogeneic transplantation in patients with hematologic malignancie…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma [Phase 3]
This entry describes a Phase 3 clinical trial evaluating lenalidomide and dexamethasone with or without bortezomib as initial treatment for …
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant [Phase 2]
This Phase 2 trial evaluated sirolimus, tacrolimus, and antithymocyte globulin to prevent graft-versus-host disease in patients with hematol…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade [Phase 2]
A Phase 2 clinical trial investigates autologous stem cell transplantation guided by minimal residual disease markers in newly diagnosed mul…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients [NA]
Completed randomized trial evaluating the duration of cryotherapy before high-dose melphalan in myeloma patients.
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant [Phase 2]
Phase 2 trial assessing thalidomide, dexamethasone, and clarithromycin in patients with multiple myeloma previously treated with transplant;…
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma [Phase 2]
Phase II study evaluating a combination of thalidomide, clarithromycin, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma …
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib [Phase 2]
Phase 2 study evaluating high-dose carfilzomib in multiple myeloma patients who progressed on standard-dose carfilzomib; the trial is comple…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease [Phase 2]
Phase 2 trial update describing donor umbilical cord blood transplantation for advanced hematologic cancers, including leukemia, lymphoma, m…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT [Phase 2]
Phase 2 trial evaluating strategies to manage diarrhea in patients with multiple myeloma undergoing conditioning chemotherapy for autologous…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma [Phase 2]
Phase II study evaluating fenofibrate therapy in patients with smoldering or symptomatic multiple myeloma has been terminated; results were …
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies [NA]
Clinical trial update for fludarabine-based conditioning prior to allogeneic transplantation in advanced hematologic malignancies; study com…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment [Phase 2]
A Phase 2 trial of tandem autologous stem cell transplantation in multiple myeloma patients with less than 12 months of prior therapy was te…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase II trial evaluating a combination of dexamethasone, thalidomide, and lenalidomide in relapsed or refractory multiple myeloma; the stud…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 study evaluating plerixafor (AMD3100) as a stem cell mobilizer for transplantation from a sibling donor in various hematologic mal…